Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region-Reference-Cited by-同舟云学术

Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region

Published:2021-05-19 Issue: Volume: Page:
ISSN:2379-5042
Container-title:mSphere
language:en
Short-container-title:mSphere

Author:

Al-Orphaly Mahmood¹,Hadi Hamad Abdel²,Eltayeb Faiha Kamaleldin³,Al-Hail Hissa¹,Samuel Bincy Gladson⁴,Sultan Ali A.⁴^ORCID,Skariah Sini⁴^ORCID

Affiliation:

1. Department of Medical Education, Weill Cornell Medicine - Qatar, Education City, Qatar Foundation, Doha, Qatar

2. Department of Infectious Diseases, Communicable Diseases Centre, Hamad Medical Corporation, Doha, Qatar

3. Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar

4. Department of Microbiology and Immunology, Weill Cornell Medicine - Qatar, Education City, Qatar Foundation, Doha, Qatar

Abstract

Over the last decades, there has been a dramatic global increase in multidrug-resistant (MDR) pathogens particularly among Gram-negative bacteria (GNB). Pseudomonas aeruginosa is responsible for various health care-associated infections, while MDR P. aeruginosa causes significant morbidity and mortality. Middle East and North Africa (MENA) represent an unexplored geographical region for the study of drug resistance since many of these countries are at crossroads of high volume of travel, diverse expatriate populations, as well as high antibiotic consumption despite attempts to implement antimicrobial stewardship programs.

Funder

QF | Qatar National Research Fund

Weill Cornell Medicine-Qatar

Publisher

American Society for Microbiology

Subject

Molecular Biology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mSphere.00202-21

Reference107 articles.

1. Centers for Disease Control and Prevention. 2019. Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention Atlanta GA. www.cdc.gov/DrugResistance/Biggest-Threats.html.

2. European Commission. 2017. EU Action on antimicrobial resistance. European Commission Brussels Belgium.

3. The Review on Antimicrobial Resistance. 2016. Tackling drug-resistant infections globally: final report and recommendations. The Review on Antimicrobial Resistance London United Kingdom. https://amr-review.org.

4. Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections

5. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of antibiogram performance and antibiotic resistance patterns in the northern Syrian region: A cross-sectional investigation;Exploratory Research in Clinical and Social Pharmacy;2024-03

2. Resistance, mechanism, and fitness cost of specific bacteriophages for Pseudomonas aeruginosa;mSphere;2024-02

3. Registry-Based Retrospective Cohort Study of Mortality among Adults Admitted to Intensive Care Units in Istanbul with Hospital Acquired Pseudomonas aeruginosa Bloodstream-Infection between 2014–2021;Antibiotics;2024-01-17

4. Antibiotic resistance profiles and associated factors of Pseudomonas Infections among patients admitted to large tertiary care hospital from a developing country;Antimicrobial Resistance & Infection Control;2023-12-20

5. Evolving trends among Pseudomonas aeruginosa: a 12-year retrospective study from the United Arab Emirates;Frontiers in Public Health;2023-11-30